No offense but what you said makes absolutely no l
Post# of 155450
Why would they do a interim look at 75 percent only to have them increase the trial size? Wouldn’t it make more sense just to say continue to 390 and finish it?
Go look at Otto Yangs paper and graph. I’m shocked the trial wasn’t stopped for efficiency this last time. I think that’s what we are aiming for, at the 75 percent mark, just need a little more data for approval.
You seem to always be negative.


CytoDyn Inc (CYDY) Stock Research Links
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com